Post on 26-Jul-2020
Annual General Meeting
Carl Zeiss Meditec AG
30 May 2017, JenaDr. Ludwin Monz, President and CEO
230 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Thank you!
To all our employees and…. my management colleagues
330 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Thank you!
To all members of the Supervisory Board
430 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Our customers - Partners in the development of new products
530 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Making blood flow visible
Prof. Dr. Andreas Raabe is the Director and Senior Consultant of the Department of Neurology at Bern University Hospital (Inselspital).
Professor Dr. Andreas Raabe in an interview with Dr. Ludwin Monz
630 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Prof. Dr. Andreas Raabe is the Director and Senior Consultant of the Department of Neurology at Bern University Hospital (Inselspital).
“What we want is absolutely clear: the best image!”
Professor Dr. Andreas Raabe in an interview with Dr. Ludwin Monz
Annual General Meeting 2017
Carl Zeiss Meditec AG
830 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Market-changing innovation in ophthalmology
IOLMaster ® 700
Contactless measurement of the eyeball More than 100 million eyes measured worldwide
930 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
ZEISS AngioPlex enables a non-invasive examination of the eye
1030 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Setting new standards - Visualization using fluorescence
OPMI® Pentero® 900
1130 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Setting new standards – Robotic visualization system with intelligent assistance functions
KINEVO 900
1230 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Better results, also from functional and esthetic perspective
EXTARO 300
1330 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Digitization means new opportunities for our business
1430 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Immediate overview of all important information
1530 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
App-assisted patient communication
Zeiss Connect App
1630 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Direct presence in most important medical technology markets
Company locations of the Carl Zeiss Meditec Group
Production, Sales, Service, R&D
Sales and Service locations of the
Carl Zeiss Meditec Group
USA, France, Spain, Germany, Japan, Turkey
1730 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Customer proximity - Crucial advantage in international competition
Company locations of the Carl Zeiss Meditec Group
Production, Sales, Service, R&D
Sales and Service locations of the
Carl Zeiss Meditec Group
USA, France, Spain, Germany, Japan, Turkey
Sales and Service locations of the ZEISS Group
1830 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Meeting our responsibilities worldwide
Annual General Meeting 2017
Carl Zeiss Meditec AG
2030 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
1 adjusted for currency effects2 Earnings before interest and tax (EBIT)3 Cash flows from operating activities
Revenue
€1,088m
Growth1
+ 2.7%
EBIT2
€154.3m
EBIT margin
14.2%
Earnings per share
€1.21
Cash flow3
€111.8m
Successful trend of past few years continuesFiscal year 2015/16
2130 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Revenue
€791.9m
Growth1
+ 4.1 %
Proportion of revenue
72.8 %
Diagnosis After-careTreatment
Ophthalmic DevicesStrong contribution to positive business development
1 Adjusted for currency effects
2230 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Revenue
€296.5m - 0.9%
Proportion of revenue
27.2 %
Visualization solutions for minimally invasive surgical treatments
MicrosurgeryStable organic growth trend
Growth1
1 Adjusted for currency effects
2330 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
EMEA
Americas
APAC
Revenue
€352.7m
Growth1
- 1.3 %
Proportion of revenue
32.4 %
€354.0m - 4.9 % 32.5 %
€381.7m + 15.5 % 35.1 %
APAC region with highest contribution to growth
1 Adjusted for currency effects
2430 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
60%
80%
100%
120%
140%
160%
180%
04.01.2016 04.01.2017
Price €45.361)
+ 60 %~ €4bn
HistoryMarket cap
+ 25 %History
Carl Zeiss Meditec AG share
TecDAX
Very good performance of Carl Zeiss Meditec AG share
1) Closing rate Xetra 29 May 2017
2530 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Dividend
€0.42
Dividend ratio
35 %
Proposed dividend
2630 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Issue price
€38.94
Funds accrued1)
€317m
Number of shares89,440,570
8.1 million shares successfully placed
1) Before incidental costs
2730 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Revenue
€587.5m
Growth1
+ 7.1 %
EBIT
€91.5m
EBIT margin
16.2 %
Continuing on road to successH1 2016/17
1 Adjusted for currency effects
2830 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Growth1 Ophthalmic Devices
+ 9.2 %
Growth1 Microsurgery
+ 1.8 %
Continuing on road to successH1 2016/17
1 Adjusted for currency effects
2930 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
- 0.6%1) + 2.7 %1) + 18.4%1)
EMEA APACAmericas
Greatest impetus for growth from APAC region
1 Adjusted for currency effects
Annual General Meeting 2017
Carl Zeiss Meditec AG
3130 May 2017Annual General Meeting of Carl Zeiss Meditec AG, Dr. Ludwin Monz
Revenue
€1.15 - 1.20bn
EBIT margin
13% - 15%
Projections for fiscal year 2016/17
Annual General Meeting
Carl Zeiss Meditec AG
30 May 2017, JenaDr. Ludwin Monz, President and CEO